" class="no-js "lang="en-US"> Companies Archive - Medtech Alert
Saturday, June 10, 2023

Breaking News

Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas Quell Therapeutics Signs Agreement with AstraZeneca to Develop and Commercialize Engineered Treg Cell Therapies for Autoimmune Diseases Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430 FDA Accepts Biologics License Applications for exagamglogene autotemcel (exa-cel) for Severe Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia Sir Richard Roberts Elected to National Academy of Sciences Rocket Pharmaceuticals Receives FDA Fast Track and Orphan Drug Designations for RP-A601 Gene Therapy for PKP2 Arrhythmogenic Cardiomyopathy (ACM) Azafaros Announces Enrollment of First Patient in Phase 2 RAINBOW Study Evaluating AZ-3102 in GM2 and NP-C Patients Kate Therapeutics Debuts With $51 Million Series A to Develop Next-Generation Genetic Medicines to Treat Muscle and Heart Diseases
1448 Results.

View Company

 Genprex | MTA

Genprex

View Company

 Alnylam | MTA

Alnylam

View Company

 Life Biosciences | MTA

Life Biosciences

View Company

 Sherlock Biosciences | MTA

Sherlock Biosciences

View Company

 Genome Insight | MTA

Genome Insight

View Company

 Synthego | MTA

Synthego

View Company

 Coeptis Therapeutics | MTA

Coeptis Therapeutics

View Company

 MIMETAS | MTA

MIMETAS

View Company

 Sonoma Biotherapeutics | MTA

Sonoma Biotherapeutics

View Company

 CRISPR Therapeutics | MTA

CRISPR Therapeutics

Load More Results